Table 2 Disease activity of the early RA patients.
Baseline | Month 3 | Month 6 | Month 12 | |
|---|---|---|---|---|
DAS28 | ||||
High (> 5.1), n (%) | 32 (61.5) | 6 (11.5) | 5 (9.6) | 3 (5.8) |
Moderate (> 3.2 and ≤ 5.1), n (%) | 19 (36.5) | 10 (19.2) | 14 (26.9) | 14 (26.9) |
Low (> 2.6 and ≤ 3.2), n (%) | 1 (1.9) | 10 (19.2) | 9 (17.3) | 7 (13.5) |
Remission (≤ 2.6), n (%) | 0 (0.0) | 26 (50.0) | 24 (46.2) | 28 (53.8) |
CDAI | ||||
High (> 22), n (%) | 30 (57.7) | 6 (11.5) | 7 (13.5) | 3 (5.8) |
Moderate (> 10 and ≤ 22), n (%) | 20 (38.5) | 6 (11.5) | 8 (15.4) | 7 (13.5) |
Low (> 2.8 and ≤ 10), n (%) | 2 (3.8) | 19 (36.5) | 15 (28.8) | 21 (40.4) |
Remission (≤ 2.8), n (%) | 0 (0.0) | 21 (40.4) | 22 (42.3) | 21 (40.4) |
SDAI | ||||
High (> 26), n (%) | 26 (50.0) | 4 (7.7) | 5 (9.6) | 2 (3.8) |
Moderate (> 11 and ≤ 26), n (%) | 24 (46.2) | 8 (15.4) | 7 (13.5) | 7 (13.5) |
Low (> 3.3 and ≤ 11), n (%) | 2 (3.8) | 18 (34.6) | 17 (32.7) | 23 (44.2) |
Remission (≤ 3.3), n (%) | 0 (0.0) | 22 (42.3) | 23 (44.2) | 20 (38.5) |
